A study to compare the effects of health related technology on monitoring of blood glucose by self in patients with high blood sugar levels in Aligarh

Augmentation Of Self Monitoring Of Blood Glucose With Digital Therapeutic Intervention In Patients With Type 2 Diabetes In Urban Aligarh: A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063351

Enrollment

136

Registered

2024-02-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Digital Therapeutic Intervention: Study participants will be divided into 3 arms- (1) Those who do not use SMBG (2) those who use SMBG three times a week and (3) thrice weekly SMBG user

Eligibility

Inclusion criteria

Inclusion criteria: 1. All diabetic patients between 30-65 years, on treatment with diet and oral hypoglycemic agents (OHA) in the urban areas of Aligarh. 2. All those who will give consent. 3. Those who have compatible smartphones and literacy for application usage.

Exclusion criteria

Exclusion criteria: 1. Pregnant women 2. Those in immunocompromised state, palliative care and seriously ill patients.

Design outcomes

Primary

Measure	Time frame
1)Attainment of glycemic control-FBS, PPBS, HbA1C 2)Lifestyle habits- Diet,physical activity, sleep, stress 3)Adherence to treatmentTimepoint: Baseline, 3 months and 6 months.	—

Secondary

Measure	Time frame
1)anthropometric parameter- BMI 2)prevention of hypoglycemiaTimepoint: Baseline, 3 months & 6 months	—

Countries

India

Contacts

Public ContactDr. Chelsea

Jawaharlal Nehru Medical College, Aligarh Muslim University

salmanshah78@gmail.com7453001978

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026